Armata Pharmaceuticals (ARMP) Net Cash Flow (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.24% |
| Dec 31, 2025 | -158.19% |
| Sep 30, 2025 | 241.68% |
| Jun 30, 2025 | -419.03% |
| Mar 31, 2025 | 129.39% |
| Dec 31, 2024 | 15.26% |
| Sep 30, 2024 | 19.13% |
| Jun 30, 2024 | -147.54% |
| Mar 31, 2024 | 328.65% |
| Dec 31, 2023 | -190.81% |
| Sep 30, 2023 | 191.75% |
| Jun 30, 2023 | -226.32% |
| Mar 31, 2023 | 195.10% |
| Dec 31, 2022 | 9.19% |
| Sep 30, 2022 | -22.97% |
| Jun 30, 2022 | -123.07% |
| Mar 31, 2022 | 2,386.35% |
| Dec 31, 2021 | 67.25% |
| Sep 30, 2021 | -11.00% |
| Jun 30, 2021 | -138.41% |
| Mar 31, 2021 | 305.36% |
| Dec 31, 2020 | -59.86% |
| Sep 30, 2020 | -2.04% |
| Jun 30, 2020 | -121.15% |
| Mar 31, 2020 | 780.32% |
| Dec 31, 2019 | 40.98% |
| Sep 30, 2019 | -164.04% |
| Jun 30, 2019 | 295.22% |
| Mar 31, 2019 | -252.65% |
| Dec 31, 2018 | 213.69% |
| Sep 30, 2018 | 0.24% |
| Jun 30, 2018 | -167.66% |
| Mar 31, 2018 | 218.55% |
| Dec 31, 2017 | -109.62% |
| Sep 30, 2017 | -118.30% |
| Jun 30, 2017 | 292.65% |
| Mar 31, 2017 | -301.20% |
| Dec 31, 2016 | 154.89% |
| Sep 30, 2016 | -5.30% |
| Jun 30, 2016 | 5.63% |